Health

Across the federal government, we continue to see how staffing issues are preventing agencies from fulfilling their mandate, at the expense of the public and to the benefit of corporate wrongdoers. The Food and Drug Administration (FDA), The Federal Emergency Management Agency (FEMA), The Environmental Protection Agency (EPA), and The Internal Revenue Service (IRS) are 4 agencies that desperately need more funding and staffing to protect and do right by the American people.

Demetrios Kouzoukas’s nomination battle offers the perfect opportunity for Democrats to prove themselves to voters.

This story has been retracted.

This week’s newsletter discusses a wolf in a moderate’s clothing, opposition to healthcare revolvers, and new polling suggesting widespread support for the CFPB.

Corporate greed and emaciated federal regulatory capacity means people are needlessly suffering physically, and sometimes even dying. That’s the upshot of two recent reports from the EPA’s Office of the Inspector General (OIG). These reports illustrate the concerning state of environmental regulation and enforcement in regards to water quality and refinery emissions. 

The White House announced late last week that the Environmental Protection Agency is launching epa.gov/cancer as part of the Biden administration’s Cancer Moonshot efforts, and will share new information about the EPA’s role in leveraging its existing authorities to “accelerate the rate of progress to prevent cancer, including phase-outs of carcinogens, regulatory actions to protect children, workers and overburdened communities, and enforcement actions to ensure pollution is curbed.” 

The Revolving Door Project’s Ananya Kalahasti and Will Royce released the following statement regarding the US Chamber of Commerce’s lawsuit regarding the Inflation Reduction Act’s Medicare prescription drug negotiation program, and a financial conflict of interest regarding the judge in the Southern District of Ohio.

While the Inflation Reduction Act might be a new approach to drug prices, Big Pharma’s strategy of suing to keep prices high is a years-old strategy.

Several states have attempted to implement automatic voter registration based on Medicare enrollment—but the Centers for Medicare and Medicaid Services is still stalling.

Mark Rohrbaugh, a mid-level staffer at the National Institutes of Health, has consistently blocked the use of march-in rights to seize patents on high-cost drugs.